Recombinant expression vector applicable to rapid screening for recombinant strain and application
US-12037632-B2 · Jul 16, 2024 · US
US10618940B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10618940-B2 |
| Application number | US-201815868136-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 11, 2018 |
| Priority date | Jan 12, 2017 |
| Publication date | Apr 14, 2020 |
| Grant date | Apr 14, 2020 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention discloses a method for increasing citrate production from genome reconstructed Aspergillus niger. The method is to insert a gene of low affinity glucose transporter, LGT1, to genome of A. niger. The expression level of LGT1 is under control of promoter Pgas. The genome reconstructed A. niger is tolerant to higher fermentation temperature and lower pH than that of the parental strain. Moreover, the production, yield and purity of product from reconstructed A. niger are higher than that of parental strain, and the fermentation time is shorter.
Opening claim text (preview).
What is claimed is: 1. A recombinant Aspergillus niger strain, comprising: a genome comprising an inserted low affinity glucose transporter gene LGT1, wherein the glucose transporter gene LGT1 transporter is under the control of a Pgas promoter, wherein the glucose transporter gene LGT1 sequence is SEQ ID NO:1, wherein the Pgas promoter sequence is SEQ ID NO:3, and wherein the A. niger strain produces a higher relative amount of citrate as compared with a wild type A. niger strain grown under identical conditions. 2. The recombinant A. niger strain according to claim 1 , wherein the glucose transporter gene LGT1 encodes a protein having the sequence SEQ ID NO:2. 3. The recombinant A. niger strain according to claim 1 , wherein the Pgas promoter controlling the expression level of LGT1 is induced by a low pH of between pH 2.0 and pH 3.5. 4. A expression cassette of LGT1 comprising a promoter of Pgas, LGT1 gene and terminator of trp in order of Pgas-LGT1-trp. 5. The expression cassette in claim 4 , wherein a sequence of Pgas is set forth in SEQ ID NO:3, an amino acid sequence of LGT1 is set forth in SEQ ID NO:2, and a sequence of trp terminator is set forth in SEQ ID NO:6. 6. The recombinant Aspergillus niger strain of claim 1 , wherein the gene sequence of glucose transporter gene LGT1 and promoter Pgas are encoded onto an expression cassette transformed into the A. niger strain. 7. The recombinant Aspergillus niger strain of claim 6 , wherein the expression cassette further comprises at least one trp terminator sequence of SEQ ID NO:6. 8. The recombinant Aspergillus niger strain of claim 6 , wherein the expression cassette further comprises a gpdA promoter sequence of SEQ ID NO:4. 9. The recombinant Aspergillus niger strain of claim 6 , wherein the expression cassette further comprises a hygromycin resistance (hph) gene sequence of SEQ ID NO:5. 10. The recombinant Aspergillus niger strain of claim 6 , wherein the expression cassette encodes a trp terminator sequence of SEQ ID NO:6, a gpdA promoter sequence of SEQ ID NO:4, and an hgh gene sequence of SEQ ID NO:5. 11. The recombinant Aspergillus niger strain of claim 10 , wherein the expression cassette sequences are in the order of gpdA-hph-trp and Pgas-LGT1-trp. 12. The recombinant Aspergillus niger strain of claim 1 , wherein the A. niger strain is derived from A. niger strain H915-1. 13. The recombinant Aspergillus niger strain of claim 1 , wherein the amount of citrate produced by the A. niger strain is at least 6.5% higher under identical conditions than a corresponding wild type Aspergillus niger strain. 14. The recombinant Aspergillus niger strain of claim 1 , wherein the amount of citrate produced by the A. niger strain is at least 40.3% higher under identical conditions than a corresponding wild type Aspergillus niger strain. 15. A method for the reconstruction of reconstructed A. niger mentioned in claim 1 , comprising the following steps: (1) constructing an expression cassette of LGT1 with Pgas-LGT1-trp; (2) Constructing a resistant gene expression cassette gpdA-hph-trp; (3) inserting expression cassette in step (1) and (2) into A. niger , screening resistant strains and confirming reconstructed strains with PCR. 16. The method in claim 15 , wherein a sequence of gpdA promoter in resistant gene cassette is set forth in SEQ ID NO: 4. 17. The method in claim 15 , wherein a sequence of resistant gene hph in resistant gene cassette is set forth in SEQ ID NO: 5. 18. A method of expressing citric acid from Aspergillus niger , which comprises: incubating an A. niger strain in growth medium comprising malt extract and tryptone at 35° C. for seven days to generate conidia, wherein the A. niger strain comprises a genome comprising a low affinity glucose transporter gene LGT1, wherein the glucose transporter gene LGT1 transporter is under the control of a Pgas promoter, wherein the glucose transporter gene LGT1 sequence is SEQ ID NO:1, and wherein the Pgas promoter sequence is SEQ ID NO:3, harvesting the conidia, inoculating seed medium with the conidia at a density of 10 6 per mL to generate a seed culture, wherein the seed medium comprises corn starch medium comprising a total sugar concentration of 10% and a total nitrogen concentration of 0.2%, growing the conidia in the seed medium at 37° C. for 24 hours at pH 3.5, inoculating a fermentation medium with the seed culture at 1/10 volume, incubating the fermentation medium for 72 hours at 42° C. at pH 2.0, centrifuging the fermented fermentation medium and discarding mycelium to obtain citric acid. 19. The method of claim 18 , wherein the A. niger strain produces a higher relative amount of citrate as compared with a wild type A. niger strain grown under identical conditions. 20. The method of claim 18 , wherein the A. niger strain produces between 6.5% and 40.3% more citrate as compared with a wild type A. niger strain under identical conditions.
Related publications grouped by family.
Answers are generated from the same data shown on this page.